COVID-19 : Athlete Q&A / World Anti-Doping Agency (WADA). - Montreal : WADA, 2020
The World Anti-Doping Agency (WADA) has published a Question and Answer (Q&A) document related to anti-doping and COVID-19, which is an update to the document that the Agency published on 23 March 2020. Once again, it was developed in consultation with WADA’s Athlete Committee.
The updated Q&A covers matters such as:
- Testing during COVID-19
- Minimizing the risk of contracting or transmitting the virus
- Filing of whereabouts information
- Validating Therapeutic Use Exemptions
- Maintaining the integrity of the global anti-doping system
- Refusing to comply with testers at this time
- Confidence in the anti-doping system
WADA will continue to liaise with athletes and Anti-Doping Organizations in the interest of publishing updates regarding the Agency’s response to COVID-19 as the situation evolves.
